De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss

Am J Nephrol. 2010;32(5):491-6. doi: 10.1159/000321328. Epub 2010 Oct 26.

Abstract

After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been reported in 7 cases, all of them between 4 weeks and 8 years after transplantation. We describe a new case of de novo TMA in association with cytomegalovirus infection 25 years after kidney transplantation.

Publication types

  • Case Reports

MeSH terms

  • Cytomegalovirus Infections / complications*
  • Cytomegalovirus Infections / drug therapy
  • Foscarnet / therapeutic use
  • Ganciclovir / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Kidney Failure, Chronic / virology*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Thrombotic Microangiopathies / drug therapy
  • Thrombotic Microangiopathies / virology*
  • Time Factors

Substances

  • Immunoglobulins, Intravenous
  • Foscarnet
  • Ganciclovir